Global Deep Brain Stimulation Devices Market

Deep Brain Stimulation Devices Comprehensive Study by Type (Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine nucleus DBS), Application (Chronic Pain, Dystonia, Essential Tremor, Depression, Obsessive compulsive disorder, Epilepsy, Parkinsons Disease, Others) Players and Region - Global Market Outlook to 2026

Deep Brain Stimulation Devices Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device known as a neurostimulator which sends electrical impulses, through implanted electrodes, to specific targets in the brain for the treatment of movement & neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for treatment resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression, and obsessive compulsive disorder (OCD).This growth is primarily driven by Increasing incidence of Parkinson’s disease and Increasing demand for minimally-invasive treatment options.

Globally, a noticeable market trend is evident Advancements in deep brain stimulation device technologies . Major Players, such as Medtronic (Ireland), Boston Scientific Corporation (United States), Enteromedics (United States), Cyberonics (United States), St. Jude Medical (United States), Neuropace (United States), Zynex (United States), Neuronetics (United States), Functional Neuromodulation (Canada) and Microtransponder (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

The global deep brain stimulation devices market is highly competitive and consolidated. The market is characterized by the presence of limited number of players. The major companies operating in this market are engaged in developing next generation devices that shall deliver better treatment outcomes, with expanded application areas with legal sanction. The companies are also actively engaged expanding their geographical reach, and improving distribution channels with partnerships and distribution agreements.

Regulatory Insights:
FDA approved DMS as a treatment for essential tremor in 1997, for Parkinson’s disease in 2002. Before this procedure, a neurosurgeon uses either MRI or CT scanning to detect the exact target area within the brain where the electric signals will generate the Parkinson’s disease symptoms.

Market Drivers
  • Increasing incidence of Parkinson’s disease
  • Increasing demand for minimally-invasive treatment options

Market Trend
  • Advancements in deep brain stimulation device technologies
  • Growing Preference for targeted therapy approach

Restraints
  • Negative impact on improving memory
  • Stringent regulatory framework

Opportunities
Increasing awareness regarding the application of deep brain stimulation device and Increasing prevalence of neurological diseases couple with growing geriatric population
Challenges
Lead to allergic reaction

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Deep Brain Stimulation Devices Study Sheds Light on
— The Deep Brain Stimulation Devices Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Deep Brain Stimulation Devices industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Deep Brain Stimulation Devices industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Subthalamic DBS
  • Globus Pallidus DBS
  • Thalamic DBS
  • Pedunculopontine nucleus DBS
By Application
  • Chronic Pain
  • Dystonia
  • Essential Tremor
  • Depression
  • Obsessive compulsive disorder
  • Epilepsy
  • Parkinsons Disease
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing incidence of Parkinson’s disease
      • 3.2.2. Increasing demand for minimally-invasive treatment options
    • 3.3. Market Challenges
      • 3.3.1. Lead to allergic reaction
    • 3.4. Market Trends
      • 3.4.1. Advancements in deep brain stimulation device technologies
      • 3.4.2. Growing Preference for targeted therapy approach
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Deep Brain Stimulation Devices, by Type, Application and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Deep Brain Stimulation Devices (Value)
      • 5.2.1. Global Deep Brain Stimulation Devices by: Type (Value)
        • 5.2.1.1. Subthalamic DBS
        • 5.2.1.2. Globus Pallidus DBS
        • 5.2.1.3. Thalamic DBS
        • 5.2.1.4. Pedunculopontine nucleus DBS
      • 5.2.2. Global Deep Brain Stimulation Devices by: Application (Value)
        • 5.2.2.1. Chronic Pain
        • 5.2.2.2. Dystonia
        • 5.2.2.3. Essential Tremor
        • 5.2.2.4. Depression
        • 5.2.2.5. Obsessive compulsive disorder
        • 5.2.2.6. Epilepsy
        • 5.2.2.7. Parkinsons Disease
        • 5.2.2.8. Others
      • 5.2.3. Global Deep Brain Stimulation Devices Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Deep Brain Stimulation Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Enteromedics (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cyberonics (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. St. Jude Medical (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Neuropace (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Zynex (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Neuronetics (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Functional Neuromodulation (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Microtransponder (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Deep Brain Stimulation Devices Sale, by Type, Application and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Deep Brain Stimulation Devices (Value)
      • 7.2.1. Global Deep Brain Stimulation Devices by: Type (Value)
        • 7.2.1.1. Subthalamic DBS
        • 7.2.1.2. Globus Pallidus DBS
        • 7.2.1.3. Thalamic DBS
        • 7.2.1.4. Pedunculopontine nucleus DBS
      • 7.2.2. Global Deep Brain Stimulation Devices by: Application (Value)
        • 7.2.2.1. Chronic Pain
        • 7.2.2.2. Dystonia
        • 7.2.2.3. Essential Tremor
        • 7.2.2.4. Depression
        • 7.2.2.5. Obsessive compulsive disorder
        • 7.2.2.6. Epilepsy
        • 7.2.2.7. Parkinsons Disease
        • 7.2.2.8. Others
      • 7.2.3. Global Deep Brain Stimulation Devices Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Deep Brain Stimulation Devices: by Type(USD Million)
  • Table 2. Deep Brain Stimulation Devices Subthalamic DBS , by Region USD Million (2015-2020)
  • Table 3. Deep Brain Stimulation Devices Globus Pallidus DBS , by Region USD Million (2015-2020)
  • Table 4. Deep Brain Stimulation Devices Thalamic DBS , by Region USD Million (2015-2020)
  • Table 5. Deep Brain Stimulation Devices Pedunculopontine nucleus DBS , by Region USD Million (2015-2020)
  • Table 6. Deep Brain Stimulation Devices: by Application(USD Million)
  • Table 7. Deep Brain Stimulation Devices Chronic Pain , by Region USD Million (2015-2020)
  • Table 8. Deep Brain Stimulation Devices Dystonia , by Region USD Million (2015-2020)
  • Table 9. Deep Brain Stimulation Devices Essential Tremor , by Region USD Million (2015-2020)
  • Table 10. Deep Brain Stimulation Devices Depression , by Region USD Million (2015-2020)
  • Table 11. Deep Brain Stimulation Devices Obsessive compulsive disorder , by Region USD Million (2015-2020)
  • Table 12. Deep Brain Stimulation Devices Epilepsy , by Region USD Million (2015-2020)
  • Table 13. Deep Brain Stimulation Devices Parkinsons Disease , by Region USD Million (2015-2020)
  • Table 14. Deep Brain Stimulation Devices Others , by Region USD Million (2015-2020)
  • Table 15. South America Deep Brain Stimulation Devices, by Country USD Million (2015-2020)
  • Table 16. South America Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 17. South America Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 18. Brazil Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 19. Brazil Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 20. Argentina Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 21. Argentina Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 22. Rest of South America Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 23. Rest of South America Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 24. Asia Pacific Deep Brain Stimulation Devices, by Country USD Million (2015-2020)
  • Table 25. Asia Pacific Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 26. Asia Pacific Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 27. China Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 28. China Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 29. Japan Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 30. Japan Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 31. India Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 32. India Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 33. South Korea Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 34. South Korea Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 35. Taiwan Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 36. Taiwan Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 37. Australia Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 38. Australia Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 39. Rest of Asia-Pacific Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 40. Rest of Asia-Pacific Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 41. Europe Deep Brain Stimulation Devices, by Country USD Million (2015-2020)
  • Table 42. Europe Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 43. Europe Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 44. Germany Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 45. Germany Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 46. France Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 47. France Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 48. Italy Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 49. Italy Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 50. United Kingdom Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 51. United Kingdom Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 52. Netherlands Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 53. Netherlands Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 54. Rest of Europe Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 55. Rest of Europe Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 56. MEA Deep Brain Stimulation Devices, by Country USD Million (2015-2020)
  • Table 57. MEA Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 58. MEA Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 59. Middle East Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 60. Middle East Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 61. Africa Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 62. Africa Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 63. North America Deep Brain Stimulation Devices, by Country USD Million (2015-2020)
  • Table 64. North America Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 65. North America Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 66. United States Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 67. United States Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 68. Canada Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 69. Canada Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 70. Mexico Deep Brain Stimulation Devices, by Type USD Million (2015-2020)
  • Table 71. Mexico Deep Brain Stimulation Devices, by Application USD Million (2015-2020)
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Deep Brain Stimulation Devices: by Type(USD Million)
  • Table 83. Deep Brain Stimulation Devices Subthalamic DBS , by Region USD Million (2021-2026)
  • Table 84. Deep Brain Stimulation Devices Globus Pallidus DBS , by Region USD Million (2021-2026)
  • Table 85. Deep Brain Stimulation Devices Thalamic DBS , by Region USD Million (2021-2026)
  • Table 86. Deep Brain Stimulation Devices Pedunculopontine nucleus DBS , by Region USD Million (2021-2026)
  • Table 87. Deep Brain Stimulation Devices: by Application(USD Million)
  • Table 88. Deep Brain Stimulation Devices Chronic Pain , by Region USD Million (2021-2026)
  • Table 89. Deep Brain Stimulation Devices Dystonia , by Region USD Million (2021-2026)
  • Table 90. Deep Brain Stimulation Devices Essential Tremor , by Region USD Million (2021-2026)
  • Table 91. Deep Brain Stimulation Devices Depression , by Region USD Million (2021-2026)
  • Table 92. Deep Brain Stimulation Devices Obsessive compulsive disorder , by Region USD Million (2021-2026)
  • Table 93. Deep Brain Stimulation Devices Epilepsy , by Region USD Million (2021-2026)
  • Table 94. Deep Brain Stimulation Devices Parkinsons Disease , by Region USD Million (2021-2026)
  • Table 95. Deep Brain Stimulation Devices Others , by Region USD Million (2021-2026)
  • Table 96. South America Deep Brain Stimulation Devices, by Country USD Million (2021-2026)
  • Table 97. South America Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 98. South America Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 99. Brazil Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 100. Brazil Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 101. Argentina Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 102. Argentina Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 103. Rest of South America Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 104. Rest of South America Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 105. Asia Pacific Deep Brain Stimulation Devices, by Country USD Million (2021-2026)
  • Table 106. Asia Pacific Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 107. Asia Pacific Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 108. China Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 109. China Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 110. Japan Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 111. Japan Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 112. India Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 113. India Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 114. South Korea Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 115. South Korea Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 116. Taiwan Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 117. Taiwan Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 118. Australia Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 119. Australia Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 120. Rest of Asia-Pacific Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 121. Rest of Asia-Pacific Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 122. Europe Deep Brain Stimulation Devices, by Country USD Million (2021-2026)
  • Table 123. Europe Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 124. Europe Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 125. Germany Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 126. Germany Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 127. France Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 128. France Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 129. Italy Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 130. Italy Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 131. United Kingdom Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 132. United Kingdom Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 133. Netherlands Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 134. Netherlands Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 135. Rest of Europe Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 136. Rest of Europe Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 137. MEA Deep Brain Stimulation Devices, by Country USD Million (2021-2026)
  • Table 138. MEA Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 139. MEA Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 140. Middle East Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 141. Middle East Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 142. Africa Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 143. Africa Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 144. North America Deep Brain Stimulation Devices, by Country USD Million (2021-2026)
  • Table 145. North America Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 146. North America Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 147. United States Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 148. United States Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 149. Canada Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 150. Canada Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 151. Mexico Deep Brain Stimulation Devices, by Type USD Million (2021-2026)
  • Table 152. Mexico Deep Brain Stimulation Devices, by Application USD Million (2021-2026)
  • Table 153. Research Programs/Design for This Report
  • Table 154. Key Data Information from Secondary Sources
  • Table 155. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Deep Brain Stimulation Devices: by Type USD Million (2015-2020)
  • Figure 5. Global Deep Brain Stimulation Devices: by Application USD Million (2015-2020)
  • Figure 6. South America Deep Brain Stimulation Devices Share (%), by Country
  • Figure 7. Asia Pacific Deep Brain Stimulation Devices Share (%), by Country
  • Figure 8. Europe Deep Brain Stimulation Devices Share (%), by Country
  • Figure 9. MEA Deep Brain Stimulation Devices Share (%), by Country
  • Figure 10. North America Deep Brain Stimulation Devices Share (%), by Country
  • Figure 11. Global Deep Brain Stimulation Devices share by Players 2020 (%)
  • Figure 12. Global Deep Brain Stimulation Devices share by Players (Top 3) 2020(%)
  • Figure 13. Global Deep Brain Stimulation Devices share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 16. Medtronic (Ireland) Revenue: by Geography 2020
  • Figure 17. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Boston Scientific Corporation (United States) Revenue: by Geography 2020
  • Figure 19. Enteromedics (United States) Revenue, Net Income and Gross profit
  • Figure 20. Enteromedics (United States) Revenue: by Geography 2020
  • Figure 21. Cyberonics (United States) Revenue, Net Income and Gross profit
  • Figure 22. Cyberonics (United States) Revenue: by Geography 2020
  • Figure 23. St. Jude Medical (United States) Revenue, Net Income and Gross profit
  • Figure 24. St. Jude Medical (United States) Revenue: by Geography 2020
  • Figure 25. Neuropace (United States) Revenue, Net Income and Gross profit
  • Figure 26. Neuropace (United States) Revenue: by Geography 2020
  • Figure 27. Zynex (United States) Revenue, Net Income and Gross profit
  • Figure 28. Zynex (United States) Revenue: by Geography 2020
  • Figure 29. Neuronetics (United States) Revenue, Net Income and Gross profit
  • Figure 30. Neuronetics (United States) Revenue: by Geography 2020
  • Figure 31. Functional Neuromodulation (Canada) Revenue, Net Income and Gross profit
  • Figure 32. Functional Neuromodulation (Canada) Revenue: by Geography 2020
  • Figure 33. Microtransponder (United States) Revenue, Net Income and Gross profit
  • Figure 34. Microtransponder (United States) Revenue: by Geography 2020
  • Figure 35. Global Deep Brain Stimulation Devices: by Type USD Million (2021-2026)
  • Figure 36. Global Deep Brain Stimulation Devices: by Application USD Million (2021-2026)
  • Figure 37. South America Deep Brain Stimulation Devices Share (%), by Country
  • Figure 38. Asia Pacific Deep Brain Stimulation Devices Share (%), by Country
  • Figure 39. Europe Deep Brain Stimulation Devices Share (%), by Country
  • Figure 40. MEA Deep Brain Stimulation Devices Share (%), by Country
  • Figure 41. North America Deep Brain Stimulation Devices Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Medtronic (Ireland)
  • Boston Scientific Corporation (United States)
  • Enteromedics (United States)
  • Cyberonics (United States)
  • St. Jude Medical (United States)
  • Neuropace (United States)
  • Zynex (United States)
  • Neuronetics (United States)
  • Functional Neuromodulation (Canada)
  • Microtransponder (United States)
Additional players considered in the study are as follows:
Neurosigma (United States) , Abbott (Malaysia) , Aleva Neurotherapeutics SA (Switzerland)
Select User Access Type

Key Highlights of Report


Sep 2021 222 Pages 51 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Deep Brain Stimulation Devices Market Quantitative research analysis
Global Deep Brain Stimulation Devices Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Deep Brain Stimulation Devices market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Deep Brain Stimulation Devices market are Medtronic (Ireland), Boston Scientific Corporation (United States), Enteromedics (United States), Cyberonics (United States), St. Jude Medical (United States), Neuropace (United States), Zynex (United States), Neuronetics (United States), Functional Neuromodulation (Canada) and Microtransponder (United States), to name a few.
is dominating the Deep Brain Stimulation Devices Market.

Know More About Global Deep Brain Stimulation Devices Market Report?

Have a Query? Click Here

Other Related Reports

Breast Pumps Comprehensive Study by Type (Manual, Battery powered, Electric), Sales (Offline, Hospitals, Baby Supply Stores, Drug Stores, Others, Online, Manufacturer website, Third Party website), P...
$ 3350
Blood Flow Measurement Devices Comprehensive Study by Type (Ultrasonic Doppler Blood Flow Meters, Laser Doppler Blood Flow Meters, Electromagnetic Blood Flow Meters), Application (Invasive (CABG, Mic...
$ 3750
Insulin Injection Pen Comprehensive Study by Type (Disposable cartridge Insulin Pens, Reusable cartridge Insulin Pens), Application (Hospital, Diabetes Clinics/ Centers, Home) Players and Region - Gl...
$ 3500
Medical Syringe Comprehensive Study by Type (Non-Disposable Syringes, Disposable Syringes (Safety Syringes, Conventional Syringes)), Application (Hospital, Clinic, Others), Distribution Channel (Onli...
$ 3500
Rigid Endoscope Comprehensive Study by Type (Global Straight-Rigid Endoscopes, Global Semi-Rigid Endoscopes), Application (Laparoscopy, Arthroscopy, Gastrointestinal endoscopy, Gynecology endoscopy, ...
$ 3750
Germicidal Lamps Comprehensive Study by Type (Low Pressure Lamps, High Pressure Lamps), Application (Biology Laboratories, Hospitals, Agricultural and Food Industry, Others) Players and Region - Glob...
$ 3500